S. 3751In Committee
Prescription Drug Supply Chain Pricing Transparency Act
Establishes prescription drug supply chain pricing transparency requirements to disclose costs and pricing practices
Plain-English overview
What this bill does
Establishes prescription drug supply chain pricing transparency requirements to disclose costs and pricing practices
Key points
- Establish pricing transparency requirements
Current status
Where it stands
Status
In Committee
Latest action
2026-01-29 — Read twice and referred to the Committee on Finance.
Related context
Topics and policy areas
undefined
